Early studies in breast cancer showed that BRD4 functions as a tumour suppressor and its overexpression in a MYC-driven murine mammary tumour cell line reduces breast cancer growth in vivo (Crawford et al, 2008; Alsarraj et al 2011). Here, MYC is linked to breast carcinoma.